Analyzing Stock...
Downloading quotes and generating insights. Please wait.
₹3047.0
-44.1 (-1.43%)
⚠️ NOT A TRADE RECOMMENDATION: These stock metrics and intraday signals are algorithmically generated based on quantitative characteristics that may be relevant to trading. Inclusion or analysis does not mean BUY, SELL or HOLD. This drilldown is a starting point for independent research, not a prediction of future price movement. Markets involve substantial risk, and you may lose some or all of your trading capital.

📊 Technical Price Chart

✨ Multi-Timeframe Trading Setup & Insights

Engine: Gemini (gemini-flash-lite-latest)

Market Analysis Summary:

"Gland Pharma (GLAND) is trading at ₹3047.0, down 1.43% on low relative volume (RVOL 0.04x). Despite weak intraday participation and a slight pullback, the broader technical structure remains strongly bullish with prices comfortably above key EMAs, a positive MACD histogram, and an ADX of 30.71 indicating a strong ongoing trend. Recent corporate developments, including a $21 million investment, favorable analyst ratings by Jefferies, and a strong Q1 earnings reaction pushing the stock near its 52-week highs, provide solid fundamental backing for medium- and long-term momentum."

Intraday (1 Day) No Intraday Trade
Conviction: 4/10
Rationale: Using intraday checkpoints: Revalidated using checkpoints up to 09:30. The extremely low volume ratio (RVOL 0.04x) combined with minor downward drift (-1.43%) indicates a lack of active institutional participation today, making intraday risk-reward unfavorable.
Entry: N/A
SL: N/A
Target: N/A
Swing (1-6 Mo) BUY
Conviction: 8/10
Rationale: The medium-term trend is supported by strong moving average alignment (trading above 20D, 50D, and 200D EMAs) and positive institutional analyst sentiment (Jefferies Buy rating). Buying near support levels offers a high probability setup for a retest of the 52-week highs.
Entry: ₹2980 - ₹3040
SL: ₹2890
Target: ₹3200
Long Term (1+ Yr) BUY
Conviction: 9/10
Rationale: Gland Pharma's fundamental catalysts, such as the recent $21 million strategic investment and robust Q1 earnings momentum, combined with a solid structural uptrend (price trading far above the 200D EMA of ₹2202.56), make it an attractive long-term compounder within the healthcare sector.
Entry: Accumulate on dips below ₹2950
SL: ₹2650
Target: ₹3600

Technical Analysis & Overview:

  • Price action is currently hovering near the VWAP of ₹3048.87. The stock holds well above its short-term 9D EMA (₹3038.55) and major medium-to-long term averages like the 50D EMA (₹2863.09) and 200D EMA (₹2384.92). The Supertrend remains bullish at ₹2814.94, and the price is well contained within the Bollinger Bands, trading below the upper band of ₹3145.74.
  • RSI(14) stands at a neutral-to-bullish 59.75, showing room for further upside without being overbought. Stochastic and StochRSI metrics are hovering in mid-range zones. The MACD line (57.0) is above the signal line (49.55) with a positive histogram (7.45), confirming sustained bullish momentum.

News & Sentiment Impact:

Recent news headlines reflect strong institutional interest and positive catalysts, including Jefferies rating the stock a 'Buy', a significant USD 21 million strategic investment, and a strong 12% post-Q1 earnings rally. These developments validate the company's growth trajectory and reinforce investor confidence, underpinning a robust medium-to-long term bullish outlook.

⚡ Intraday Live Validation DETERIORATING

Entry Decision
🟡 WAIT (Pending)
Position Health
⚠️ AT RISK (Tighten SL)
Session VWAP ₹3048.87
Peak Drawdown from High -0.53%
Intraday 5m EMA9 / EMA20 ₹3051.69 / ₹3051.95
Audit Reason: MOMENTUM_PULLBACK (-0.5% off high / Below 5m EMA9 Rs.3051.69)

⏱️ Intraday Checkpoints Timeline

09:30 -1.22% (0.44x) ⛔ AVOID ⚠️ RISK

📊 Price Action Metrics

Open Price ₹3040.2
Day's High ₹3063.3
Day's Low ₹3015.9
VWAP ₹3048.87
Distance from Day's High 0.53%
Distance from Day's Low 1.03%
52-Week High ₹3171.0
52-Week Low ₹1573.6

📈 Volume & Participation

Current Volume 16119
20-Day Avg Volume 398384.35
Relative Volume (RVOL) 0.04x
Nifty 50 Change 0.0%
Relative Strength vs. Nifty -1.43%

🎯 Comprehensive Technical Indicators Matrix Multi-Period SMAs, EMAs, Oscillators, Bands & Real-Time Verdicts

Indicator & Parameters Calculated Value(s) & Multi-Period Signals Verdict & Bias
RSI (14) 59.75 Bullish (55–70)
Average True Range (ATR 14) ₹92.04 (3.02% of Price) Neutral / Normal
Stochastics (14, 3) %K: 62.41 %D: 70.04 Bearish (%K < %D)
StochRSI (14) %K: 61.32 %D: 65.31 Bearish (%K < %D)
ADX (14) & DMI ADX: 30.71 +DI: 24.54 -DI: 12.45 Strong Bullish Trend (+DI)
Ultimate Oscillator (UO) 61.16 Bullish
Rate of Change (ROC 12) & Momentum ROC: 4.45% Momentum (10D): ₹57.3 Bullish (+ROC)
Williams %R (14) -37.59 Bullish
MACD (12, 26, 9) MACD: 57.0 Signal: 49.55 Histogram: 7.45 Bullish (Line > Signal)
Supertrend (10, 3) ₹2814.94 (Bullish) Bullish Trend
Bollinger Bands (20, 2) Upper: ₹3145.74 Mid: ₹2968.15 Lower: ₹2790.56 Bullish (Above Mid)
Parabolic SAR ₹2880.44 Bullish (Price > SAR)
Commodity Channel Index (CCI 20) 74.52 Neutral
Simple Moving Averages (SMAs) 20D: ₹2968.15 34D: ₹2947.7 50D: ₹2897.11 89D: ₹2677.82 200D: ₹2202.56 Bullish (Price > 20D > 50D)
Exponential Moving Averages (EMAs) 9D: ₹3038.55 20D: ₹2989.25 34D: ₹2933.47 50D: ₹2863.09 89D: ₹2692.42 200D: ₹2384.92 Bullish Stack (Price > 9D > 20D)
TRIX (15) 0.226% Bullish (>0)

📰 Latest Google News & Corporate Updates

GLAND Share Price Today - Gland Pharma Ltd. Stock Price Live NSE/BSE - Univest
Publisher: Univest | Published: Mon, 12 Oct 2026 11:30:00
Gland Pharma Limited (GLAND.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Publisher: Yahoo! Finance Canada | Published: Fri, 09 Oct 2026 09:59:58
Gland Pharma invests USD 21 million as Jefferies rates Gland Pharma stock Buy - ad-hoc-news.de
Publisher: ad-hoc-news.de | Published: Wed, 14 Oct 2026 04:22:22
Gland Pharma (NSEI:GLAND) Stock Forecast & Analyst Predictions - Simply Wall Street
Publisher: Simply Wall Street | Published: Fri, 09 Oct 2026 07:00:00
Gland Pharma rallies 12%, stock hits 4-year high post Q1 results - Business Standard
Publisher: Business Standard | Published: Tue, 11 Aug 2026 07:00:00

📚 Technical Indicator & Strategy Definitions

SMAs (Simple Moving Averages): Arithmetic mean of closing prices over multiple trading periods (20D, 34D, 50D, 89D, 200D). Price trading above the 200-day SMA indicates a long-term secular bull trend, while 20D/50D track short-to-medium term institutional support levels.
EMAs (Exponential Moving Averages): Weighted moving averages placing greater priority on recent price bars (9D, 20D, 34D, 50D, 89D, 200D). A progressive stack (EMA 9 > 20 > 50) confirms robust upward momentum and provides dynamic support during pullbacks.
ADX (Average Directional Index - 14) & DMI: Measures trend strength regardless of direction. An ADX value ≥ 25 confirms a strong trending market. Directional Movement (+DI / -DI) indicates which side is in control: +DI > -DI is bullish (buyers dominant), whereas -DI > +DI indicates bearish seller control.
VWAP (Volume Weighted Average Price): The average price weighted by intraday volume. Used as a benchmark by institutional participants; price trading above VWAP indicates intraday buyer control, while trading below VWAP indicates intraday seller pressure.
RSI (Relative Strength Index - 14) & StochRSI: Momentum oscillator measuring speed and magnitude of price movements (0–100). RSI > 70 is overbought; RSI < 30 is oversold; 50–60 signals bullish continuation. StochRSI applies stochastics to RSI to generate early inflection signals for trend shifts.
MACD (Moving Average Convergence Divergence): Trend-following momentum indicator displaying the spread between the 12 and 26-period EMAs against a 9-period signal line. MACD crossing above Signal is bullish; rising histogram bars signal accelerating upward momentum.
RVOL (Relative Volume Ratio): Compares current session volume against the 20-day historical average. RVOL ≥ 2.0x signals abnormal institutional participation, confirming the validity of breakouts and trend expansions.
Bollinger Bands (20, 2): Statistical volatility bands set ±2 standard deviations around a 20-period SMA. Contracting bandwidth ('squeeze') signals an impending explosive breakout, while price walking the upper band confirms aggressive trend expansion.
ATR (Average True Range - 14): Quantifies absolute market volatility in rupee terms over a 14-period lookback. Essential for setting volatility-adjusted trailing stop-losses, target sizing, and detecting range expansions.
Supertrend (10, 3): Volatility-based trend-following indicator calculated with ATR. Provides clear Bullish (green trailing line below price) or Bearish (red line above price) regimes to manage active trade trailing stops.
Stochastic Oscillator (%K, %D): Locates current closing price relative to the 14-period high-low range. Fast line (%K) crossing above smooth line (%D) in oversold territory (<20) confirms a buy reversal signal; crosses above 80 warn of overbought conditions.
CCI (Commodity Channel Index - 20): Measures price variation relative to its statistical average. CCI crossing above +100 signals strong uptrend breakout; crossing below -100 indicates deep downward momentum; zero-line cross marks cycle shifts.
Parabolic SAR (Stop and Reverse): Trailing stop overlay that follows price acceleration. When dots plot below price, the trend is bullish; a flip above price triggers trailing stop protection.
Williams %R (14) & TRIX (15): Williams %R reflects momentum relative to lookback highs (-20 to 0 overbought, -80 to -100 oversold). TRIX is a triple-smoothed EMA rate-of-change oscillator filtering noise to capture major cyclical momentum waves.
Relative Strength (vs. Nifty): Measures the percentage outperformance or underperformance against the benchmark Nifty 50 Index. Positive values identify leading stocks commanding institutional capital flow.
Intraday Regime & Permission Gates: 4-gate hierarchical risk firewall evaluating intraday structure, volume effort vs result at day highs, ATR peak drawdown, and VWAP integrity to prevent buying into collapsing peaks.
Opportunity Score (0 – 100) & Risk Score (0 – 100): Dual independent quantitative ratings: Opportunity Score (≥75 top-tier setup) evaluates momentum, volume, pattern, sector tailwinds, and RS. Risk Score (<50 preferred) evaluates drawdown history, resistance proximity, and volatility.
Setup Archetypes: Algorithmic classification: Breakout Candidate (near 20D/52W high with expansion), Pullback Continuation (EMA20 retest in uptrend), Momentum Continuation (high RS5D + ATR expansion), and Reversal Candidate (extended mean-reversion).